Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Effectiveness and Safety of BMS-986165 Compared to Placebo and Active Comparator in Participants With Psoriasis

ClinicalTrials.gov ID: NCT03624127

Public ClinicalTrials.gov record NCT03624127. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 2:13 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center, Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Phase 3 Study to Evaluate the Efficacy and Safety of BMS-986165 in Subjects With Moderate-to-Severe Plaque Psoriasis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to investigate the experimental medication BMS-986165 compared to placebo and a currently available treatment in participants with moderate to severe plaque psoriasis.

Study identification

NCT ID
NCT03624127
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
666 participants

Conditions and interventions

Conditions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 7, 2018 (Actual)
Primary completion
Sep 2, 2020 (Actual)
Completion
Sep 2, 2020 (Actual)
Last update posted
Jan 30, 2023

2018 – 2020

United States locations

U.S. sites
67
U.S. states
28
U.S. cities
60
Facility City State ZIP Site status
Achieve Clinical Research Birmingham Alabama 35216 —
Coastal Clinical Research - Mobile Mobile Alabama 36608 —
Elite Clinical Studies Phoenix Arizona 85018 —
Arizona Research Center Phoenix Arizona 85053 —
Synexus - Tucson Tucson Arizona 85741 —
Hull Dermatology Rogers Arkansas 72758 —
First OC Dermatology & Belle-Aimee Skincare Clinic Fountain Valley Fountain Valley California 92708 —
University California at Irvine Dermatology Clinical Research Center Irvine California 92697 —
Keck School of Medicine Los Angeles California 90033 —
Dream Team Clinical Research Pomona California 91767 —
University Dermatology Group San Diego California 92123 —
Unison Clinical Trials Sherman Oaks California 91403 —
New England Research Associates Bridgeport Connecticut 06606 —
Precision Clinical Research Davie Florida 33328 —
Indago Research and Health Center Hialeah Florida 33012 —
LCC Medical Research Miami Florida 33126 —
International Dermatology Research Miami Florida 33144 —
Well Pharma Medical Research Miami Florida 33173 —
Miami Dade Medical Research Institute Miami Florida 33176 —
San Marcus Research Clinic Miami Lakes Florida 33014 —
Renstar Medical Research Ocala Florida 34471 —
Ameriderm Research Ormond Beach Florida 32174 —
Olympian Clinical Research Tampa Florida 33614-7118 —
Palm Beach Research Center West Palm Beach Florida 33409-3401 —
Hamilton Dermatology Alpharetta Georgia 30022 —
Healthcare Research Network - Flossmoor Flossmoor Illinois 60402 —
Springfield Clinic Springfield Illinois 62703 —
Deaconess Clinic Downtown Evansville Indiana 47708 —
The Dermatology Center New Albany Indiana 47150 —
The Indiana Clinical Trials Center Plainfield Indiana 46168 —
The South Bend Clinic South Bend Indiana 46617 —
Kansas City Dermatology Overland Park Kansas 66215 —
Dermatology Specialists Research-Kentucky Louisville Kentucky 40241 —
Clinical Trials of America - Monroe Monroe Louisiana 71201 —
Etre Cosmetic Dermatology and Laser Center New Orleans Louisiana 70130 —
ActivMed Practices and Research - Beverly Beverly Massachusetts 01915 —
DermCare Experts Quincy Massachusetts 02169 —
David Fivenson MD Dermatology Ann Arbor Michigan 48103 —
Somerset Skin Centre Troy Michigan 48084 —
Associated Skin Care Specialists - Minnesota Clinical Study Center New Brighton Minnesota 55112 —
MediSearch Clinical Trials Saint Joseph Missouri 64506 —
Dartmouth-Hitchcock Medical Center Lebanon New Hampshire 03756 —
Hassman Research Institute Berlin New Jersey 08009 —
Forest Hills Dermatology Group Kew Gardens New York 11374 —
Mount Sinai - Queens New York New York 10023 —
PMG Research of Charlotte Charlotte North Carolina 28209 —
Duke University Health System - Duke Clinic Durham North Carolina 27710-4000 —
M3 Wake Research, Inc. Raleigh North Carolina 27612 —
The Ohio State University Wexner Medical Center Columbus Ohio 43203 —
Synexus - Columbus Columbus Ohio 43212 —
Health Research of Oklahoma Oklahoma City Oklahoma 73103-2433 —
Oregon Medical Research Center Portland Oregon 97223-6683 —
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213 —
Clinical Research Center of Reading Wyomissing Pennsylvania 19610 —
Synexus Clinical Research - Anderson Anderson South Carolina 29621 —
Clinical Research Center of the Carolinas Charleston South Carolina 29407 —
Interspond - Stones River Dermatology - Murfreesboro Office Murfreesboro Tennessee 37129 —
Westlake Dermatology - Westlake Austin Texas 78746 —
Dermatology Treatment and Research Center Dallas Texas 75230 —
Metroplex Clinical Research Center Dallas Texas 75231 —
Menter Dermatology Research Institute Dallas Texas 75246 —
Austin Institute for Clinical Research - Pflugerville Pflugerville Texas 78660 —
University of Texas Health Science Center at San Antonio San Antonio Texas 78218 —
Interspond - Acclaim Dermatology Sugar Land Texas 77479 —
Center for Clinical Studies - Webster Webster Texas 77598 —
Dermatology Associates of Seattle Seattle Washington 98101 —
Eastern Washington Dermatology Walla Walla Washington 99362 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 98 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03624127, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 30, 2023 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03624127 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →